| 1 |
29799521 | Heat shock factor 1 confers resistance to lapatinib in ERBB2-positive breast cancer cells. | 2018 May 24 |
1 |
| 2 |
28464908 | A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer. | 2017 May 2 |
1 |
| 3 |
27172793 | The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma. | 2016 Jun 14 |
1 |
| 4 |
27590506 | A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer. | 2016 Sep 27 |
1 |
| 5 |
24862757 | Activation of HER3 interferes with antitumor effects of Axl receptor tyrosine kinase inhibitors: suggestion of combination therapy. | 2014 Apr |
2 |
| 6 |
19671800 | Novel mechanism of lapatinib resistance in HER2-positive breast tumor cells: activation of AXL. | 2009 Sep 1 |
3 |